Why the study?
Does intrapericardial methylprednisolone improve clinical outcomes in a patient with recurrent pericardial effusion due to acute lymphoblastic leukemia?
Does intrapericardial methylprednisolone improve clinical outcomes in a patient with recurrent pericardial effusion due to acute lymphoblastic leukemia?
Intrapericardial steroid injection may be a beneficial therapeutic option for patients with paraneoplastic syndrome and recurrent pericardial effusion.
No takes yet. Share an insight, caveat, or question.
May warrant consideration in refractory leukemia-related effusion; leaves open need for prospective trials before practice change.
Mainzer et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: